Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →21
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
41,315
Total Claims
$1.5M
Drug Cost
2,709
Beneficiaries
$544
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+36%
Opioid rate vs peers
62.6% vs 45.9% avg
+13%
Cost per patient vs peers
$544 vs $483 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
62.6%
Opioid Rate
25,861
Opioid Claims
$841K
Opioid Cost
6.0%
Long-Acting Rate
This provider's opioid prescribing rate of 62.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 0 claims · $0
Generic: 40,583 claims · $1.1M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Hydrocodone/Acetaminophen | 12,800 | $322K |
| Oxycodone Hcl/Acetaminophen | 7,125 | $242K |
| Oxycodone Hcl/Acetaminophen | 25 | $94K |
| Diclofenac Sodium | 585 | $73K |
| Gabapentin | 3,280 | $72K |
| Naloxegol Oxalate | 150 | $71K |
| Rimegepant Sulfate | 42 | $61K |
| Oxycodone Hcl | 2,258 | $45K |
| Linaclotide | 51 | $33K |
| Cyclobenzaprine Hcl | 1,872 | $32K |
| Oxycodone Myristate | 64 | $30K |
| Tizanidine Hcl | 1,592 | $29K |
| Pregabalin | 926 | $25K |
| Morphine Sulfate | 1,173 | $24K |
| Erenumab-Aooe | 24 | $22K |
Prescribing Profile
51
Unique Drugs
21.0
Anomaly Score
Patient Profile
65
Avg Age
62%
Female
2.13
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data